<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Am Heart J</journal-id><journal-id journal-id-type="iso-abbrev">Am. Heart J.</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>American heart journal</journal-title></journal-title-group><issn pub-type="ppub">0002-8703</issn><issn pub-type="epub">1097-6744</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3777661</article-id><article-id pub-id-type="pmcid-ver">PMC3777661.1</article-id><article-id pub-id-type="pmcaid">3777661</article-id><article-id pub-id-type="pmcaiid">3777661</article-id><article-id pub-id-type="manuscript-id">NIHMS481193</article-id><article-id pub-id-type="pmid">23067921</article-id><article-id pub-id-type="doi">10.1016/j.ahj.2012.07.004</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS481193</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA481193</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hess</surname><given-names initials="CN">Connie N.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Broderick</surname><given-names initials="S">Samuel</given-names></name><degrees>MS</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Piccini</surname><given-names initials="JP">Jonathan P.</given-names></name><degrees>MD, MHS</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alexander</surname><given-names initials="KP">Karen P.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Newby</surname><given-names initials="LK">L. Kristin</given-names></name><degrees>MD, MHS</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shaw</surname><given-names initials="LK">Linda K.</given-names></name><degrees>MS</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mahaffey</surname><given-names initials="KW">Kenneth W.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alexander</surname><given-names initials="JH">John H.</given-names></name><degrees>MD, MHS</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peterson</surname><given-names initials="ED">Eric D.</given-names></name><degrees>MD, MPH</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Granger</surname><given-names initials="CB">Christopher B.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lopes</surname><given-names initials="RD">Renato D.</given-names></name><degrees>MD, PhD</degrees></contrib><aff id="A1">Duke Clinical Research Institute, Durham, NC.</aff></contrib-group><author-notes><corresp id="CR1">Reprint requests: Renato D. Lopes, MD, PhD, MHS, Box 3850, 2400 Pratt St, Room 0311 Terrace Level, Durham, NC 27705. <email>renato.lopes@duke.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2012</year></pub-date><volume>164</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">227619</issue-id><fpage>607</fpage><lpage>615</lpage><pub-history><event event-type="nihms-submitted"><date><day>30</day><month>08</month><year>2013</year></date></event><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2013</year></date></event><event event-type="pmc-live"><date><day>01</day><month>10</month><year>2013</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-05 22:06:41.443"><day>05</day><month>06</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2012, Mosby, Inc. All rights reserved.</copyright-statement><copyright-year>2012</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-481193.pdf"/><abstract><sec id="S1"><title>Background</title><p id="P1">Older patients with atrial fibrillation (AF) and coronary artery disease (CAD) face high risk of stroke and bleeding with antithrombotic therapy. Balancing safe and effective use of aspirin, clopidogrel, and warfarin in this population is important.</p></sec><sec id="S2"><title>Methods</title><p id="P2">From the Duke Databank for Cardiovascular Disease, we identified patients with AF &#8805;65 years old with angiographically confirmed CAD from 2000 to 2010. Antithrombotic use was described across age and Congestive heart failure, Hypertension, Age &gt;75 years, Diabetes, prior Stroke/transient ischemic attack (CHADS<sub>2</sub>) stroke risk and Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) bleeding scores. Death and the composite of death, myocardial infarction, and stroke by antithrombotic strategy were reported.</p></sec><sec id="S3"><title>Results</title><p id="P3">Of 2,122 patients &#8805;65 years old with AF and CAD, 477 (22.5%) were &#8805;80 years old; 1,133 (53.4%) had acute coronary syndromes. Overall rates of aspirin, clopidogrel, and warfarin use were 83.4%, 34.6%, and 38.9%, respectively. Compared with patients 65 to 79 years old, more patients &#8805;80 years old were at high stroke risk (CHADS<sub>2</sub> &#8805;2, 84.7% vs 57.8%) and high bleeding risk (ATRIA 5-10, 55.8% vs 23.3%). Warfarin use in both age groups increased with higher CHADS<sub>2</sub> scores and decreased with higher ATRIA scores. Of patients &#8805;80 years old with CHADS<sub>2</sub> &#8805;2, 150 (38.2%) received warfarin. Antithrombotic strategy was not associated with improved 1-year adjusted outcomes.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">Among older patients with AF and CAD, overall warfarin use was low. Patients &#8805;80 years old at highest stroke risk received warfarin in similar proportions to the overall cohort. Further investigation into optimizing antithrombotic strategies in this population is warranted.</p></sec></abstract><funding-group><award-group><funding-source country="United States">National Heart, Lung, and Blood Institute : NHLBI</funding-source><award-id>T32 HL069749 || HL</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>